Company / Operating Cash Flow per Share
Olema Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.78
FY2024
5-year range
-$2.83 / -$1.28
FY2020-FY2024
Trend
+4.0%
vs FY2023
Sector context
#142 of 212
Health Care
What the data says
At $-1.78, Olema Pharmaceuticals, Inc.'s operating cash flow per share ranks #142 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-2.83 in FY2020 to $-1.19 in FY2019.
Based on SEC 10-K filings.
-1.78 in FY2024.
Improved from $-2.05 to $-1.78 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#142 of 212 in Health CareTop 67% of 212This company -$1.78 Sector average -$14.72
▼
+87.9% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 4.0% year-over-year.
- Ranks #142 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.78 | +4.0% |
| FY2023 | -$1.85 | +9.8% |
| FY2022 | -$2.05 | -60.0% |
| FY2021 | -$1.28 | +54.7% |
| FY2020 | -$2.83 | -138.1% |
| FY2019 | -$1.19 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026